Correlation Between Neurocrine Biosciences and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Aquestive Therapeutics, you can compare the effects of market volatilities on Neurocrine Biosciences and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Aquestive Therapeutics.
Diversification Opportunities for Neurocrine Biosciences and Aquestive Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neurocrine and Aquestive is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Aquestive Therapeutics
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.53 times more return on investment than Aquestive Therapeutics. However, Neurocrine Biosciences is 1.9 times less risky than Aquestive Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 11,620 in Neurocrine Biosciences on August 28, 2024 and sell it today you would earn a total of 1,091 from holding Neurocrine Biosciences or generate 9.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Aquestive Therapeutics
Performance |
| Timeline |
| Neurocrine Biosciences |
| Aquestive Therapeutics |
Neurocrine Biosciences and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Aquestive Therapeutics
The main advantage of trading using opposite Neurocrine Biosciences and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
| Aquestive Therapeutics vs. Capricor Therapeutics | Aquestive Therapeutics vs. Soleno Therapeutics | Aquestive Therapeutics vs. Bio Path Holdings | Aquestive Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |